Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation

N. Senst, M. Llacuachaqui, J. Lubinski, Henry T. Lynch, S. Armel, S. Neuhausen, P. Ghadirian, P. Sun, Sa Narod

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The objective is to estimate the risk of breast cancer in women who carry a deleterious BRCA1 or BRCA2 mutation, according to parental origin of mutation. We conducted a cohort study of women with a BRCA1 mutation (n=1523) or BRCA2 mutation (n=369) who had not been diagnosed with breast or ovarian cancer. For each woman, the pedigree was reviewed and the origin of the mutation was assigned as probable paternal or maternal. The hazard ratio (HR) for developing breast cancer in the follow-up period was estimated for women with a paternal mutation compared to a maternal mutation. The risk of breast cancer was modestly higher in women with a paternal BRCA1 mutation compared to women with a maternal BRCA1 mutation (HR=1.46; 95% CI=0.99-2.16) but the difference was not significant (p=0.06). The parental mutation origin did not affect the risk in women with a BRCA2 mutation. Our results are consistent with the hypothesis that there is an increased risk of breast cancer among women with a paternally inherited BRCA1 mutation compared to a maternally inherited mutation. However, the data are not sufficiently compelling to justify different screening recommendations for the two subgroups.

Original languageEnglish
Pages (from-to)43-46
Number of pages4
JournalClinical Genetics
Volume84
Issue number1
DOIs
StatePublished - Jul 2013

Fingerprint

Prospective Studies
Breast Neoplasms
Mutation
Mothers
Pedigree
Ovarian Neoplasms
Cohort Studies

All Science Journal Classification (ASJC) codes

  • Genetics(clinical)
  • Genetics

Cite this

Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation. / Senst, N.; Llacuachaqui, M.; Lubinski, J.; Lynch, Henry T.; Armel, S.; Neuhausen, S.; Ghadirian, P.; Sun, P.; Narod, Sa.

In: Clinical Genetics, Vol. 84, No. 1, 07.2013, p. 43-46.

Research output: Contribution to journalArticle

Senst, N, Llacuachaqui, M, Lubinski, J, Lynch, HT, Armel, S, Neuhausen, S, Ghadirian, P, Sun, P & Narod, S 2013, 'Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation', Clinical Genetics, vol. 84, no. 1, pp. 43-46. https://doi.org/10.1111/cge.12037
Senst, N. ; Llacuachaqui, M. ; Lubinski, J. ; Lynch, Henry T. ; Armel, S. ; Neuhausen, S. ; Ghadirian, P. ; Sun, P. ; Narod, Sa. / Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation. In: Clinical Genetics. 2013 ; Vol. 84, No. 1. pp. 43-46.
@article{a473c2b77ae84e3186a8c8b80c23f73a,
title = "Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation",
abstract = "The objective is to estimate the risk of breast cancer in women who carry a deleterious BRCA1 or BRCA2 mutation, according to parental origin of mutation. We conducted a cohort study of women with a BRCA1 mutation (n=1523) or BRCA2 mutation (n=369) who had not been diagnosed with breast or ovarian cancer. For each woman, the pedigree was reviewed and the origin of the mutation was assigned as probable paternal or maternal. The hazard ratio (HR) for developing breast cancer in the follow-up period was estimated for women with a paternal mutation compared to a maternal mutation. The risk of breast cancer was modestly higher in women with a paternal BRCA1 mutation compared to women with a maternal BRCA1 mutation (HR=1.46; 95{\%} CI=0.99-2.16) but the difference was not significant (p=0.06). The parental mutation origin did not affect the risk in women with a BRCA2 mutation. Our results are consistent with the hypothesis that there is an increased risk of breast cancer among women with a paternally inherited BRCA1 mutation compared to a maternally inherited mutation. However, the data are not sufficiently compelling to justify different screening recommendations for the two subgroups.",
author = "N. Senst and M. Llacuachaqui and J. Lubinski and Lynch, {Henry T.} and S. Armel and S. Neuhausen and P. Ghadirian and P. Sun and Sa Narod",
year = "2013",
month = "7",
doi = "10.1111/cge.12037",
language = "English",
volume = "84",
pages = "43--46",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation

AU - Senst, N.

AU - Llacuachaqui, M.

AU - Lubinski, J.

AU - Lynch, Henry T.

AU - Armel, S.

AU - Neuhausen, S.

AU - Ghadirian, P.

AU - Sun, P.

AU - Narod, Sa

PY - 2013/7

Y1 - 2013/7

N2 - The objective is to estimate the risk of breast cancer in women who carry a deleterious BRCA1 or BRCA2 mutation, according to parental origin of mutation. We conducted a cohort study of women with a BRCA1 mutation (n=1523) or BRCA2 mutation (n=369) who had not been diagnosed with breast or ovarian cancer. For each woman, the pedigree was reviewed and the origin of the mutation was assigned as probable paternal or maternal. The hazard ratio (HR) for developing breast cancer in the follow-up period was estimated for women with a paternal mutation compared to a maternal mutation. The risk of breast cancer was modestly higher in women with a paternal BRCA1 mutation compared to women with a maternal BRCA1 mutation (HR=1.46; 95% CI=0.99-2.16) but the difference was not significant (p=0.06). The parental mutation origin did not affect the risk in women with a BRCA2 mutation. Our results are consistent with the hypothesis that there is an increased risk of breast cancer among women with a paternally inherited BRCA1 mutation compared to a maternally inherited mutation. However, the data are not sufficiently compelling to justify different screening recommendations for the two subgroups.

AB - The objective is to estimate the risk of breast cancer in women who carry a deleterious BRCA1 or BRCA2 mutation, according to parental origin of mutation. We conducted a cohort study of women with a BRCA1 mutation (n=1523) or BRCA2 mutation (n=369) who had not been diagnosed with breast or ovarian cancer. For each woman, the pedigree was reviewed and the origin of the mutation was assigned as probable paternal or maternal. The hazard ratio (HR) for developing breast cancer in the follow-up period was estimated for women with a paternal mutation compared to a maternal mutation. The risk of breast cancer was modestly higher in women with a paternal BRCA1 mutation compared to women with a maternal BRCA1 mutation (HR=1.46; 95% CI=0.99-2.16) but the difference was not significant (p=0.06). The parental mutation origin did not affect the risk in women with a BRCA2 mutation. Our results are consistent with the hypothesis that there is an increased risk of breast cancer among women with a paternally inherited BRCA1 mutation compared to a maternally inherited mutation. However, the data are not sufficiently compelling to justify different screening recommendations for the two subgroups.

UR - http://www.scopus.com/inward/record.url?scp=84879793634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879793634&partnerID=8YFLogxK

U2 - 10.1111/cge.12037

DO - 10.1111/cge.12037

M3 - Article

VL - 84

SP - 43

EP - 46

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 1

ER -